Sep 27, 2022 / 12:00PM GMT
Hedi Ben Brahim - Transgene SA - CEO & Director
Hello, everyone. Thanks - Thank you very much for being here, either in person via webcast or in the replay. It's a great pleasure to have you here with you today with our management team and our leading clinicians from around the world who will share their enthusiasm on our development.
Today, we have the honor to be hosting Jean-Pierre Delord, MD-PhD, General Manager of IUCT Oncopole of Toulouse; Adel Samson, MD-PhD, Clinical Associate Professor, CAI U.K., Clinician Scientist and Honorary Medical Oncologist for the University of Leeds; and Pedro Romero, MD Chief Editor of the JITC and Deputy Scientific Imaging Director of the Lausanne branch of the Ludwig Institute for Cancer Research, who are here with us in person. Also, Christian Ottensmeier, MD-PhD, FRCP, Professor of Immuno-oncology at the University of Liverpool, The Clatterbridge Cancer Center, NHS Foundation Trust; and Matthew Block, MD-PhD, Medical Oncologist at the Mayo Clinic, who will participate remotely. Having their support today gives us a lot of confidence on the products that
Transgene SA R&D Day Transcript
Mar 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers